JIA Junjie,JIANG De,CHEN Yifei,et al.Effects of Different Degrees of "Dryness Pathogen" on the PGD2/EOS Axis in the Lung Tissue of Bronchial Asthma Model Rats[J].Journal of Traditional Chinese Medicine,2026,67(20):2219-2226. DOI: 10.13288/j.11-2166/r.2026.20.012.
JIA Junjie,JIANG De,CHEN Yifei,et al.Effects of Different Degrees of "Dryness Pathogen" on the PGD2/EOS Axis in the Lung Tissue of Bronchial Asthma Model Rats[J].Journal of Traditional Chinese Medicine,2026,67(20):2219-2226. DOI: 10.13288/j.11-2166/r.2026.20.012.DOI:
Effects of Different Degrees of "Dryness Pathogen" on the PGD2/EOS Axis in the Lung Tissue of Bronchial Asthma Model Rats
To explore the effects of "dryness pathogen" on a bronchial asthma rat model from the perspective of the prostaglandin D
2
(PGD
2
)/eosinophil (EOS) axis.
Methods
2
Forty SD rats were randomly divided into five groups, blank group, asthma group, mild dryness asthma group, moderate dryness asthma group, and severe dryness asthma group, with 8 rats in each group. The asthma model was induced in the asthma group using ovalbumin (OVA), while the asthma-dryness syndrome groups were modeled using a climate chamber combined with OVA to establish animal models of bronchial asthma with Northwest dryness syndrome. During modeling, general behavioral performance of the rats in each group was observed and recorded, and body weight, water intake, and asthma symptom scores were compared. On day 21 of the modeling, small animal respiratory system testing was used to measure respiratory rate and intermittent respiratory contraction index. Pathological changes in rat lung tissues were observed using HE staining. Giemsa staining was used to observe eosinophil (EOS) infiltration in lung tissues and calculate EOS counts. ELISA was used to detect serum levels of prostaglandin D
2
(PGD
2
), interleukin-5 (IL-5), and interleukin-4 (IL-4). Western Blot was used to detect eosinophil peroxidase (EPX) and prostaglandin D
2
receptor (CRTH2) protein levels in rat lung tissues.
Results
2
Compared to the blank group, the average water intake of rats in all asthma-dryness groups increased (
P
<0.01). The body weight of rats decreased in the moderate and severe asthma-dryness groups on day 14, and in all modelling groups on day 21 (
P
<0.05 or
P
<0.01). Across all model groups, the asthma symptom score, respiratory rate,
intermittent respiratory contraction index, EOS count in lung tissue, serum levels of PGD
2
, IL-5, and IL-4, as well as the relative protein expression levels of EPX and CRTH2 in lung tissue all significantly increased (
P
<0.01). Compared to the asthma group, the water intake of rats in the mild, moderate, and severe asthma-dryness groups increased (
P
<0.01). On day 21 of the experiment, the body weight of rats in the moderate and severe asthma-dryness groups decreased (
P
<0.05), and the respiratory rate of rats in all asthma-dryness groups increased, as well as the serum levels of PGD
2
, IL-5, and IL-4, and the relative protein expression levels of EPX and CRTH2 in lung tissues (
P
<0.05 or
P
<0.01). Furthermore, in the moderate and severe asthma-dryness groups, the asthma symptom scores and intermittent respiratory contraction indices were elevated, and the EOS counts in lung tissue increased (
P
<0.05 or
P
<0.01). Compared to the mild asthma-dryness group, serum levels of PGD
2
, IL-5, and IL-4 in the severe asthma-dryness group increased, as well as the relative protein expression levels of EPX and CRTH2 in lung tissue (
P
<0.05 or
P
<0.01). Pathological observation showed that rats in all asthma-dryness syndrome groups exhibited increased inflammatory infiltration in the lung tissue, alveolar wall thickening, luminal narrowing, pulmonary interstitial congestion, and aggravated viscous secretions. These pathological manifestations worsened as the degree of dryness increased.
Conclusion
2
The "dryness pathogenic factor" can exacerbate bronchial asthma symptoms and lung tissue pathological damage through the PGD
2
/EOS axis, and the damage progressively worsens with the increasing severity of the dryness pathogen.
关键词
Keywords
references
Huang K , Yang T , Xu J , et al . Prevalence, risk factors, and management of asthma in China: a national cross-sectional study [J]. Lancet , 2019 , 394 ( 10196 ): 407 - 418 .
Mormile M , Mormile I , Fuschillo S , et al . Eosinophilic airway diseases: from pathophysiological mechanisms to clinical practice [J/OL]. Int J Mol Sci , 2023 , 24 ( 8 ): 7254 . https://pubmed.ncbi.nlm.nih.gov/37108417/ https://pubmed.ncbi.nlm.nih.gov/37108417/ .
Venegas G C , Mukherjee M , Svenningsen S , et al . Eosinophil-mucus interplay in severe asthma: implications for treatment with biologicals [J]. Allergol Int , 2024 , 73 ( 3 ): 351 - 361 .
Metcalfe D D , Pawankar R , Ackerman S J , et al . Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases [J/OL]. World Allergy Organ J , 2016 , 9 : 7 . https://pubmed.ncbi.nlm.nih.gov/26904159/ https://pubmed.ncbi.nlm.nih.gov/26904159/ .
Hussain M , Liu G . Eosinophilic asthma: pathophysiology and therapeutic horizons [J/OL]. Cells , 2024 , 13 ( 5 ): 384 . https://doi.org/10.3390/cells13050384 https://doi.org/10.3390/cells13050384 .
Carstensen S , Gress C , Erpenbeck V J , et al . Prostaglandin D2 metabolites activate asthmatic patient-derived type 2 innate lymphoid cells and eosinophils via the DP2 receptor [J/OL]. Respir Res , 2021 , 22 ( 1 ): 262 . https://doi.org/10.1186/s12931-021-01852-3 https://doi.org/10.1186/s12931-021-01852-3 .
Kips J C , Tournoy K G , Pauwels R A . New anti-asthma therapies:suppression of the effect of interleukin (IL)-4 and IL-5 [J]. Eur Respir J , 2001 , 17 ( 3 ): 499 - 506 .
Siddiqui S , Bachert C , Bjermer L , et al . Eosinophils and tissue remodeling: relevance to airway disease [J]. J Allergy Clin Immunol , 2023 , 152 ( 4 ): 841 - 857 .
Oh C K , Geba G P , Molfino N . Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma [J]. Eur Respir Rev , 2010 , 19 ( 115 ): 46 - 54 .
Differentiating and Treating Comorbidities of Childhood Asthma in Cold Regions Based on the Theory of "Syndrome-Based Disease Regulation": An Approach from Dampness,Heat,and Phlegm
Effect of Qingfei Shenshi Decoction (清肺渗湿汤) Combined with Western Medicine on Clinical Effectiveness and Immune Function for Patients with Bronchial Asthma of Heat Wheezing Syndrome
ZHOU Zhaoshan's Experience in Staged Treatment of Bronchial Asthma by Draining Dampness
Effects of Moxibustion at "Feishu (BL 13)" and "Tianshux (ST 25) Bronchial Asthma Model Rats Acupoints on M2 Polarization of Macrophages in Lung Tissue in Bronchial Asthma Model Rats
Stage Differentiation and Treatment of Pediatric Bronchial Asthma Based on the Struggling Between Healthy Qi and Pathogenic Qi
Related Author
ZHANG Meng
SHI Mengdi
WANG Yijie
LIU Lujia
WANG Luodi
GUO Tingting
WANG Youpeng
SUN Ying
Related Institution
The First Affiliated Hospital of Heilongjiang University of Chinese Medicine
The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine
Heilongjiang University of Chinese Medicine
First Clinical Medical College,Shandong University of Traditional Chinese Medicine
Qingdao Traditional Chinese Medicine Hospital (Qingdao Hiser Hospital)